SBC Medical Group Holdings (SBC) AI Stock Analysis

• Market Cap: $430.85M
• Dividend Yield: N/A
• Average Volume (3M): 65.67K
• Price to Earnings (P/E): 12.9
• Beta (1Y): 0.76
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 863
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): 0.02
• Shares Outstanding: 102,705,956
• 10 Day Avg. Volume: 48,167
• 30 Day Avg. Volume: 65,672
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.80
• Enterprise Value/Revenue: 1.82
• Enterprise Value/Gross Profit: 2.38
• Enterprise Value/Ebitda: 5.09
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 64 Neutral
• Price Target: $3.50 ▲(7.36% Upside)

SBC Medical Group Holdings demonstrates strong financial performance with robust profitability and a solid balance sheet, contributing positively to the overall score. However, technical analysis indicates bearish momentum, which negatively impacts the stock's attractiveness. The valuation is reasonable, but the lack of a dividend yield may deter some investors. The absence of earnings call data and corporate events means these factors do not influence the score.

SBC Medical Group Holdings Business Overview & Revenue Model

Company Description

SBC Medical Group Holdings (SBC) is a healthcare organization that specializes in providing a diverse array of medical services, including primary care, specialty care, and ancillary services. Operating primarily in the healthcare sector, SBC aims to enhance patient outcomes through innovative treatments and a patient-centric approach. The company also focuses on integrating technology into healthcare delivery, offering telemedicine services and electronic health record systems to streamline patient interactions and improve efficiency.

How the Company Makes Money

SBC Medical Group Holdings generates revenue through multiple streams that include fee-for-service payments from patients for medical consultations and treatments, capitated payment arrangements with health insurance providers, and reimbursement from government programs such as Medicare and Medicaid. Additionally, the company may earn income from ancillary services such as laboratory testing, imaging services, and pharmacy operations. Strategic partnerships with insurance companies and healthcare networks further enhance SBC's revenue potential by expanding its patient base and facilitating cost-effective care delivery.

SBC Medical Group Holdings Financial Statement Overview

Summary

SBC Medical Group Holdings demonstrates strong financial health with consistent revenue growth and robust profitability. A low leverage and high equity ratio provide financial stability, though there's room for improvement in cash conversion efficiency and asset utilization.

Income Statement

SBC Medical Group Holdings demonstrates strong financial performance with consistent revenue growth, evidenced by a 6.1% increase from 2023 to 2024. The company maintains robust profitability, with a gross profit margin of 75.9% and a net profit margin of 22.7% in 2024. EBIT and EBITDA margins are also healthy at 34.2% and 37.6%, respectively, indicating efficient operations and cost management. The upward trajectory in revenue and profitability highlights the company's strong market position and operational efficiency.

Balance Sheet

The balance sheet reflects a solid financial foundation with a low debt-to-equity ratio of 0.06, indicating minimal leverage and financial risk. The equity ratio is strong at 73.3%, showcasing a high level of financial stability and asset backing. Return on equity is impressive at 23.9%, reflecting effective use of shareholder funds to generate profits. The company's strong equity position and low leverage provide a stable financial base, though there is room for improvement in optimizing asset utilization.

Cash Flow

SBC Medical Group Holdings shows a positive cash flow trajectory with a significant turnaround in free cash flow from negative in 2022 to positive in subsequent years. The free cash flow to net income ratio is 0.37 in 2024, indicating a healthy conversion of profits into cash. Operating cash flow to net income ratio stands at 0.44, suggesting moderate efficiency in cash generation from operations. While cash flow metrics are improving, further enhancement in cash conversion efficiency would strengthen the company's liquidity position.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	188.19M	205.42M	193.54M	174.16M
Gross Profit	144.38M	156.05M	137.30M	114.83M
EBITDA	67.42M	77.28M	85.87M	29.64M
Net Income	33.33M	46.61M	39.37M	6.32M
Balance Sheet
Total Assets	315.30M	266.08M	258.81M	225.48M
Cash, Cash Equivalents and Short-Term Investments	152.74M	125.04M	103.02M	53.64M
Total Debt	15.53M	12.21M	22.87M	16.13M
Total Liabilities	70.65M	71.06M	115.00M	117.63M
Stockholders Equity	244.59M	195.11M	142.16M	105.25M
Cash Flow
Free Cash Flow	-11.81M	17.17M	39.44M	-24.99M
Operating Cash Flow	-8.70M	20.58M	50.64M	-47.37K
Investing Cash Flow	14.70M	-10.10M	1.82M	-32.65M
Financing Cash Flow	29.98M	22.97M	6.14M	-7.98M

SBC Medical Group Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.26
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SBC, the sentiment is Negative. The current price of 3.26 is below the 20-day moving average (MA) of 3.94, below the 50-day MA of 4.17, and below the 200-day MA of 4.25, indicating a bearish trend. The MACD of -0.23 indicates Positive momentum. The RSI at 24.84 is Positive, neither overbought nor oversold. The STOCH value of 3.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SBC.

SBC Medical Group Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRAI	―	$1.25B	22.91	27.83%	1.06%	8.69%	34.58%
FC	―	$214.66M	21.47	15.47%	―	-0.40%	-40.98%
SBC	―	$430.85M	12.89	26.08%	―	―	―
Sector *	―	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
RGP	―	$143.58M	-0.75	-61.44%	9.55%	-10.83%	-1669.11%
FORR	―	$136.06M	―	―	―	-8.73%	-1168.15%
AERT	―	$31.58M	―	―	―	-5.47%	-113.35%

SBC Medical Group Holdings Corporate Events

SBC Medical Group Reports Q2 2025 Financial Results

SBC Medical Group Holdings Incorporated is a global company that owns, operates, and provides management services and products to cosmetic treatment centers, primarily focusing on franchise clinics. Headquartered in Irvine, California, and Tokyo, Japan, the company offers a wide range of services including advertising, staff management, and medical equipment procurement.